Predialysis systolic BP variability and outcomes in hemodialysis patients

Journal of the American Society of Nephrology

Volumn 25, Issue 4, 2014, Pages 799-809

  Shafi, Tariq ^a,b   Sozio, Stephen M ^a,b   Bandeen Roche, Karen J ^c   Ephraim, Patti L ^a,b   Luly, Jason R ^c   St Peter, Wendy L ^d,e   McDermott, Aidan ^c   Scialla, Julia J ^f   Crews, Deidra C ^a,b   Tangri, Navdeep ^g   Miskulin, Dana C ^h   Michels, Wieneke M ^b   Jaar, Bernard G ^a,b,i   Herzog, Charles A ^d,e   Zager, Philip G ^j   Meyer, Klemens B ^h   Wu, Albert W ^c   Boulware, L Ebony ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MANITOBA   (Canada)

^h TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NEPHROLOGY CENTER OF MARYLAND   (United States)

^j UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM PHOSPHATE; HEMOGLOBIN; SERUM ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ADVERSE OUTCOME; AGE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OBESITY; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; AGED; DRUG EFFECT; MIDDLE AGED; RENAL REPLACEMENT THERAPY; SYSTOLE; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; SYSTOLE; TREATMENT OUTCOME;

EID: 84901473153     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013060667     Document Type: Article

References (33)

1. Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG: Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 115: 291-297, 2003
2. Levin NW, Kotanko P, Eckardt KU, Kasiske BL, Chazot C, Cheung AK, Redon J, Wheeler DC, Zoccali C, London GM: Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int 77: 273-284, 2010
3. WeirMR: Debate from the 2012 ASH Annual Scientific Sessions: Should blood pressure be reduced in hemodialysis patients? Con position. J Am Soc Hypertens 6: 443-447, 2012
4. Agarwal RL: Debate from the 2012 ASH Annual ScientificSessions: Should blood pressure be reduced in hemodialysis patients? Pro position. J Am Soc Hypertens 6: 439-442, 2012
5. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S, Kopple JD: Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: The 58th annual fall conference and scientific sessions. Hypertension 45: 811-817, 2005
6. Li Z, Lacson E Jr., Lowrie EG, Ofsthun NJ, Kuhlmann MK, Lazarus JM, Levin NW: The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 48: 606-615, 2006
7. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, Young EW: Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 33: 507-517, 1999
8. Robinson BM, Tong L, Zhang J, Wolfe RA, Goodkin DA, Greenwood RN, Kerr PG, Morgenstern H, Li Y, Pisoni RL, Saran R, Tentori F, Akizawa T, Fukuhara S, Port FK: Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 82: 570-580, 2012
9. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P: "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 54:561-569, 1998
10. Flythe JE, Kunaparaju S, Dinesh K, Cape K, Feldman HI, Brunelli SM: Factors associated with intradialytic systolic blood pressure variability. Am J Kidney Dis 59: 409-418, 2012
11. Mancia G: Prognostic value of long-term blood pressure variability: The evidence is growing. Hypertension 57: 141-143, 2011
12. Rossignol P, Kessler M, Zannad F: Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases. Curr Opin Nephrol Hypertens 22: 59-64, 2013
13. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlòf B, Sever PS, Poulter NR: Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375: 895-905, 2010
14. Brunelli SM, Thadhani RI, Lynch KE, Ankers ED, Joffe MM, Boston R, Chang Y, Feldman HI: Association between long-term blood pressure variability and mortality among incident hemodialysis patients. Am J Kidney Dis 52: 716-726, 2008
15. US Renal Data System: USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2012
16. Rothwell PM: Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 375: 938-948, 2010
17. Muntner P, Levitan EB, Reynolds K, Mann DM, Tonelli M, Oparil S, Shimbo D: Within-visit variability of blood pressure and all-cause and cardiovascular mortality among US adults. J Clin Hypertens (Greenwich) 14: 165-171, 2012
18. Chang TI, Flythe JE, Brunelli SM, Muntner P, Greene T, Cheung AK, Chertow GM: Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis [published online ahead of print June 27, 2013]. J Hum Hypertens 10.1038/jhh.2013.49
19. Chertow GM, Levin NW, BeckGJ, DepnerTA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, KligerAS; FHN Trial Group: In-center hemodialysis six times per week versus three times per week. N Engl J Med 363: 2287-2300, 2010
20. Webb AJ, Fischer U, Mehta Z, Rothwell PM: Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: A systematic review and meta-analysis. Lancet 375: 906-915, 2010
21. Agarwal R: Managing hypertension using home blood pressure monitoring among haemodialysis patients-a call to action. Nephrol Dial Transplant 25: 1766-1771, 2010
22. Agarwal R, Brim NJ, Mahenthiran J, Andersen MJ, Saha C: Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy. Hypertension 47: 62-68, 2006
23. Moriya H, Oka M, Maesato K, Mano T, Ikee R, Ohtake T, Kobayashi S: Weeklyaveraged blood pressure is more important than a single-point blood pressure measurement in the risk stratification of dialysis patients. Clin J Am Soc Nephrol 3: 416-422, 2008
24. InrigJK, OddoneEZ, HasselbladV, GillespieB, Patel UD, ReddanD, TotoR, Himmelfarb J, Winchester JF, Stivelman J, Lindsay RM, Szczech LA: Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. KidneyInt 71: 454-461, 2007
25. Van Buren PN, Kim C, Toto R, Inrig JK: Intradialytic hypertension and the association with interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 6: 1684-1691, 2011
26. Converse RL Jr., Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG: Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327: 1912-1918, 1992
27. Inrig JK, Van Buren P, Kim C, Vongpatanasin W, Povsic TJ, Toto R: Probing the mechanisms of intradialytic hypertension: A pilot study targeting endothelial cell dysfunction. Clin J Am Soc Nephrol 7:1300-1309, 2012
28. Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, Bòhm M, Lambert EA, Krum H, Sobotka PA, Schmieder RE, Ika-Sari C, Eikelis N, Straznicky N, Lambert GW, Esler MD: Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. Int J Cardiol 168:2214-2220, 2013
29. K/DOQI Workgroup: K/DOQI Clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45[4 Suppl 3]: 16-153, 2005
30. Boulware LE, Tangri N, Ephraim PL, Scialla JJ, Sozio SM, Crews DC, Shafi T, Miskulin DC, Liu J, St Peter W, Jaar BG, Wu AW, Powe NR, Navaneethan SD, Bandeen-Roche K; DEcIDE ESRD Patient Outcomes in Renal Disease Study Investigators: Comparative effectiveness studies to improve clinical outcomesin end stage renal disease: The DEcIDE patient outcomes in end stage renal disease study. BMC Nephrol 13: 167, 2012
31. Liu J, Huang Z, Gilbertson DT, Foley RN, Collins AJ: An improved co-morbidity index for outcome analyses among dialysis patients. Kidney Int 77: 141-151, 2010
32. Prentice RL, Kalbfleisch JD, Peterson AV Jr., Flournoy N, Farewell VT, Breslow NE: The analysis of failure times in the presence of competing risks. Biometrics 34: 541-554, 1978
33. Zeger SL, Liang K-Y: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42: 121-130, 1986